Female infertility associated with anovulation. Female infertility, unspecified
Conditions
Interventions
Intervention 1: In group without intervention ( Control): only antagonist 25 miligram daily is administrated from the second day of the cycle. In all three groups of patients after 6 days of treatmen
Treatment - Drugs
In group without intervention ( Control): only antagonist 25 miligram daily is administrated from the second day of the cycle. In all three groups of patients after 6 days of treatment, vaginal ultra
In intervention group 1: daily treatment is a pill (OCP) for 10 days and 10-12 days before the last cycle. In all three groups of patients after 6 days of treatment, vaginal ultrasound will be done ev
In intervention group 2: daily treatment is a Estradiol Pill for 10 days and before the start of Antagonist administration. In all three groups of patients after 6 days of treatment, vaginal ultraso
Sponsors
Vice Chancellor for Research, Tehran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
20 Years to 35 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: women with 20-35 years old; prior IVF less than 2; AFC>4; FSH<10; without any pathology in ovary or endometrioma more than 1cm; without any hydrosalpinx. Exclusion criteria: PCOS; pathology in uterus or ovary ( myoma larger than 5 cm); absence of vaginal bleeding until 6 days after disconnection of OCP or E2; lack of permission of patients.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Oocyte number. Timepoint: Six days after treatment. Method of measurement: Vaginal sonography.;Number of induction ovulation. Timepoint: After treatment. Method of measurement: Transvaginal sonography. | — |
Secondary
| Measure | Time frame |
|---|---|
| Chemical pregnancy. Timepoint: 14 days after embryo transfer. Method of measurement: B-HCG Test.;Clinical pregnancy. Timepoint: Three weeks after do positive of pregnancy teset. Method of measurement: Transvaginal sonography. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFatemeh Bakhtiari
Reproductive Health Research Center
Outcome results
None listed